RetinalGenix Technologies Inc.
RTGN · OTCMCIK 1836295fmd_1B64HN7DKCM3NDVWZ5VT03EP7FManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2026, 26 periods
RetinalGenix Technologies Inc. (RTGN) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Net income | -$2.4 million | -$4.3 million | 10-K 2026-04-15 · proof | |
| Cash from operating activities | -$558,350 | -$741,936 | 10-K 2026-04-15 · proof | |
| Total assets | $21,041 | $14,946 | +40.8% | 10-K 2026-04-15 · proof |
| Total liabilities | $2.3 million | $1.5 million | +57.3% | 10-K 2026-04-15 · proof |
| Cash and cash equivalents | $14,774 | $6,060 | +143.8% | 10-K 2026-04-15 · proof |
- What was RetinalGenix Technologies Inc. (RTGN)'s net income in fiscal 2025?
- RetinalGenix Technologies Inc. (RTGN) reported net income of -$2.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$4.3 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was RetinalGenix Technologies Inc. (RTGN)'s cash from operating activities in fiscal 2025?
- RetinalGenix Technologies Inc. (RTGN) reported cash from operating activities of -$558,350 for fiscal 2025 (the year ended Dec 31, 2025), against -$741,936 the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are RetinalGenix Technologies Inc. (RTGN)'s total assets?
- As of Dec 31, 2025, RetinalGenix Technologies Inc. (RTGN) reported total assets of $21,041, against $14,946 a year earlier (+40.8%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are RetinalGenix Technologies Inc. (RTGN)'s total liabilities?
- As of Dec 31, 2025, RetinalGenix Technologies Inc. (RTGN) reported total liabilities of $2.3 million, against $1.5 million a year earlier (+57.3%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are RetinalGenix Technologies Inc. (RTGN)'s cash and cash equivalents?
- As of Dec 31, 2025, RetinalGenix Technologies Inc. (RTGN) reported cash and cash equivalents of $14,774, against $6,060 a year earlier (+143.8%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:RTGN&period_type=annual&limit=5"Information only, not investment advice.